Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

NCT05935176 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidemic Meningitis

Interventions

BIOLOGICAL: MCV4
BIOLOGICAL: MCV4
BIOLOGICAL: MCV4

Sponsor

CanSino Biologics Inc.